Barry Gibney to Recombinant Fusion Proteins
This is a "connection" page, showing publications Barry Gibney has written about Recombinant Fusion Proteins.
Connection Strength
0.045
-
Phase I Trial Characterizing the Pharmacokinetic Profile of N-803, a Chimeric IL-15 Superagonist, in Healthy Volunteers. J Immunol. 2022 03 15; 208(6):1362-1370.
Score: 0.045
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.